News | November 09, 2023
Bayer posts Q3 2023 Group sales Euro 10.34 billion
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
PhytoSquene now available for clinical and commercial use
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
The composition of ORAAL is protected by a granted patent in India until November 2033
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated
